Mannitol is an osmotic diuretic commonly used to reduce intracranial pressure. While various side-effects, including hyperosmolar states, precipitate reduction in intracranial pressure, rebound phenomenon and hypervolaemia have been described, hypotension due to rapid administration has not been widely recognised.
Our occasional use of 20070 mannitol prior to craniotomy made us suspect that serious hypotension could result following too rapid administration. Cardiovascular parameters were therefore documented in 6 consecutive cases when mannitol was employed. A search of the literature disclosed one report of hypotension following mannitol administration in patients undergoing cardiac surgery. I CASE REPORTS All patients were managed as follows: Premedication was with oral diazepam and metoclopramide given one hour before leaving the ward. Monitoring was set up before induction and included ECG and direct arterial blood pressure measurement. Continuous recording was with a two-channel Hewlett Packard paper recorder running at a speed of 10 mm per minute.
Induction was carried out using thiopentone (5-10 mg/kg), Fentanyl (1-2 microg/kg), and d-tubocurarine (1 mg/kg). The drugs were administered slowly and ventilation maintained with nitrous oxide 4 lImin and oxygen 2 lImin.
The following manoeuvres were employed to maintain cardiovascular stability, as required -insertion of an oral airway, spraying of the vocal cords with topical lignocaine, and volume administration. Intubation was eventually carried out after about 10 minutes. Subsequently ventilation was adjusted to an end-tidal Pcoz approximating 30 mmHg.
When cardiovascular stability had been maintained for 10 minutes after application of the Mayfield head holder (about half an hour from the time of induction), mannitol 20% was given intravenously, initially slowly (about 50 mllmin for about two minutes) and then if no major cardiovascular change occurred, as rapidly as the drip would allow for about 15 to 20 seconds. This represented a volume of 60-80 ml. The drip was then slowed and the changes in heart rate and blood pressure were noted. The total dose of mannitol eventually given in each case was 19/kg.
Case 1 was a fit 35-year-old woman undergoing craniotomy for removal of a large frontal meningioma. The anaesthetic was uneventful until the administration of mannitol.
Case 2 was a 26-year-old woman having a craniotomy for clipping of anterior communicating artery aneurysm. Bronchospasm developed on induction and for this 125 mg of aminophyline was given intravenously, with resolution prior to administration of mannitol. Case 3 was a 35-year-old woman also undergoing surgery for intracranial aneurysm. Induction was uneventful.
Case 4 was a 60-year-old man undergoing craniotomy for removal of an intraventricular meningioma. Induction was uneventful.
Case 5 was a 57-year-old woman with a large frontal meningioma. This patient had been on pindolol 5 mg tds for arterial hypertension. Induction was uneventful.
Case 6 was a fit 61-year-old woman undergoing craniotomy for intracranial aneurysm. Induction was uneventful. Table 1 shows the changes in cardiovascular parameters which occurred on rapid administration of mannitol. In all cases a significant fall in blood pressure occurred. Figure 1 demonstrates the fall which occurred in Case 1. Our study would indicate that 200/0 mannitol causes hypotension in neurosurgical patients when infused rapidly. Because of lack of awareness of this side-effect of the drug, and as the phenomenon has not been described in neurosurgical patients, publication of this report was considered worthwhile. Our results are consistent with those of Cote, Greenhow and Marshall, who studied the effects of mannitol in cardiac patients, as well as in rabbits.
Their human studies were on 24 patients having coronary artery surgery. Six patients were given 25% mannitol, 0.125 g/kg at a mean rate of 0.16 g/kg/sec prior to cardiopulmonary bypass. This resulted in a drop of peripheral resistance and blood pressure, and a rise in cardiac output. Eighteen patients were given mannitol at various rates during cardiopulmonary bypass, where the cardiac output is fixed by the pump. Again there was a drop in peripheral resistance and blood pressure, the degree of which was proportional to the dose and rate of administration.
In the animal experiments, 25% mannitol, 31 % glucose and isotonic saline were administered rapidly to groups of rabbits. With mannitol and hypertonic glucose, there was a drop in blood pressure which was proportional to the dose and rate of administration. No such change occurred when isotonic saline was administered. Using radioactive micro spheres the authors showed that the hypotension was due to vasodilatation in the skeletal muscle of the rabbits.
We occasionally administer 20% mannitol prior to the craniotomy in a dose of 1.0 g/kg given over about 10 minutes. This study was prompted by the fact that we observed unexplained hypotension in a patient where mannitol was inadvertently given at a much more rapid rate. We initially had plans for a much larger series, but in the light of consistent results, we considered for ethical reasons continuation of the study unjustifiable. For the same reasons, and also as the work had already been done by Cote, Greenhow and Marshall, we did not proceed with the next step, namely, investigation of the cause of the hypotension. We have no reason to believe that it should be any different in neurosurgical patients.
Our conclusions are that mannitol generally results in hypotension if given excessively rapidly. The blood pressure usually returns to normal in two minutes if the infusion rate is slowed. As mannitol is often given to patients with raised intracranial pressure in whom it is important that blood pressure and cerebral perfusion pressure be well maintained we recommend that the drug not be administered too rapidly and that arterial pressure be monitored closely during the administration.
